These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23023338)
1. Size frequency distributions of β-amyloid (Aβ) deposits: a comparative study of four neurodegenerative disorders. Armstrong RA Folia Neuropathol; 2012; 50(3):240-9. PubMed ID: 23023338 [TBL] [Abstract][Full Text] [Related]
2. Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology. Armstrong RA; Cairns NJ Neurol Sci; 2009 Dec; 30(6):471-7. PubMed ID: 19768369 [TBL] [Abstract][Full Text] [Related]
3. Cortical laminar distribution of β-amyloid deposits in five neurodegenerative disorders. A Armstrong R Folia Neuropathol; 2020; 58(1):1-9. PubMed ID: 32337952 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the spatial patterns of β-amyloid (Aβ) deposits in five neurodegenerative disorders. A Armstrong R Folia Neuropathol; 2018; 56(4):284-292. PubMed ID: 30786665 [TBL] [Abstract][Full Text] [Related]
5. Do beta-amyloid (Abeta) deposits in patients with Alzheimer's disease and Down's syndrome grow according to the log-normal model? Armstrong RA Neurosci Lett; 1999 Feb; 261(1-2):97-100. PubMed ID: 10081936 [TBL] [Abstract][Full Text] [Related]
6. Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer's disease. Armstrong RA Am J Alzheimers Dis Other Demen; 2006; 21(3):175-81. PubMed ID: 16869338 [TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease. Armstrong RA; Cairns NJ; Lantos PL Dement Geriatr Cogn Disord; 2000; 11(4):187-92. PubMed ID: 10867443 [TBL] [Abstract][Full Text] [Related]
8. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Armstrong RA Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269 [TBL] [Abstract][Full Text] [Related]
9. β-amyloid (Aβ) deposition in cognitively normal brain, dementia with Lewy bodies, and Alzheimer's disease: a study using principal components analysis. Armstrong RA Folia Neuropathol; 2012; 50(2):130-9. PubMed ID: 22773458 [TBL] [Abstract][Full Text] [Related]
10. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains. Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380 [TBL] [Abstract][Full Text] [Related]
11. The spatial patterns of beta/A4 deposit subtypes in Down's syndrome. Amstrong RA Acta Neuropathol; 1994; 88(4):353-8. PubMed ID: 7839828 [TBL] [Abstract][Full Text] [Related]
12. Spatial correlations between beta-amyloid (Abeta) deposits and blood vessels in familial Alzheimer's disease. Armstrong RA Folia Neuropathol; 2008; 46(4):241-8. PubMed ID: 19169965 [TBL] [Abstract][Full Text] [Related]
13. beta-Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Armstrong RA; Cairns NJ; Lantos PL Neurosci Lett; 1997 May; 227(3):193-6. PubMed ID: 9185683 [TBL] [Abstract][Full Text] [Related]
14. Size frequency distributions of abnormal protein deposits in Alzheimer's disease and variant Creutzfeldt-Jakob disease. Armstrong RA Folia Neuropathol; 2007; 45(3):108-14. PubMed ID: 17849360 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Mann DM; Jones D; Prinja D; Purkiss MS Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007 [TBL] [Abstract][Full Text] [Related]
16. Rates of cerebral atrophy differ in different degenerative pathologies. Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250 [TBL] [Abstract][Full Text] [Related]
17. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Marui W; Iseki E; Kato M; Akatsu H; Kosaka K Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805 [TBL] [Abstract][Full Text] [Related]
18. Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome. Head E; Garzon-Rodriguez W; Johnson JK; Lott IT; Cotman CW; Glabe C Neurobiol Dis; 2001 Oct; 8(5):792-806. PubMed ID: 11592849 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome. Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642 [TBL] [Abstract][Full Text] [Related]
20. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain. Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]